Pages that link to "Q48010361"

The following pages link to Mefloquine distribution in postmortem cases (Q48010361):

Displaying 20 items.

• Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain (Q24619923) (← links)
• The acute neurotoxicity of mefloquine may be mediated through a disruption of calcium homeostasis and ER function in vitro (Q24800302) (← links)
• Malaria Prevention, Mefloquine Neurotoxicity, Neuropsychiatric Illness, and Risk-Benefit Analysis in the Australian Defence Force (Q26770267) (← links)
• Mefloquine and psychotomimetics share neurotransmitter receptor and transporter interactions in vitro (Q28307141) (← links)
• Idiosyncratic quinoline central nervous system toxicity: Historical insights into the chronic neurological sequelae of mefloquine (Q33892018) (← links)
• Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy (Q34110804) (← links)
• The antimalarial potential of 4-quinolinecarbinolamines may be limited due to neurotoxicity and cross-resistance in mefloquine-resistant Plasmodium falciparum strains (Q35124519) (← links)
• Complex Membrane Channel Blockade: A Unifying Hypothesis for the Prodromal and Acute Neuropsychiatric Sequelae Resulting from Exposure to the Antimalarial Drug Mefloquine (Q36241478) (← links)
• Mefloquine-induced disruption of calcium homeostasis in mammalian cells is similar to that induced by ionomycin (Q36424992) (← links)
• Use of mefloquine in multidrug-resistant Mycobacterium avium complex pulmonary disease in an HIV-negative patient (Q37672748) (← links)
• Transcriptional profiling of mefloquine-induced disruption of calcium homeostasis in neurons in vitro (Q38321992) (← links)
• Identification and characterization of mefloquine efficacy against JC virus in vitro (Q39877627) (← links)
• Epileptogenic potential of mefloquine chemoprophylaxis: a pathogenic hypothesis (Q39957773) (← links)
• Limbic encephalopathy and central vestibulopathy caused by mefloquine: A case report (Q41929827) (← links)
• Sequential changes in the non-coding control region sequences of JC polyomaviruses from the cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy (Q42287198) (← links)
• Synthesis and biological evaluation of the first pentafluorosulfanyl analogs of mefloquine (Q42463398) (← links)
• Mefloquine Blockade of Connexin 36 and Connexin 43 Gap Junctions and Risk of Suicide (Q48937298) (← links)
• The Mefloquine Intoxication Syndrome: A Significant Potential Confounder in the Diagnosis and Management of PTSD and Other Chronic Deployment-Related Neuropsychiatric Disorders (Q56656020) (← links)
• Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a review (Q90310182) (← links)
• FDA Black Box, VA Red Ink? A Successful Service-Connected Disability Claim for Chronic Neuropsychiatric Adverse Effects From Mefloquine (Q91599281) (← links)